Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy

Cinzia Ingallina, Pedro M. Costa, Francesca Ghirga, Rebecca Klippstein, Julie T. Wang, Simone Berardozzi, Naomi Hodgins, Paola Infante, Steven M. Pollard, Bruno Botta*, Khuloud T. Al-Jamal

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)
209 Downloads (Pure)

Abstract

Aim: With the purpose of delivering high doses of glabrescione B (GlaB) to solid tumors after systemic administration, long-circulating GlaB-loaded oil-cored polymeric nanocapsules (NC-GlaB) were formulated. Materials & methods: Synthesis of GlaB and its encapsulation in nanocapsules (NCs) was performed. Empty and GlaB-loaded NCs were assessed for their physico-chemical properties, in vitro cytotoxicity and in vivo biodistribution. Results: GlaB was efficiently loaded into NCs (90%), which were small (160 nm), homogeneous and stable upon storage. Further, GlaB and NC-GlaB demonstrated specific activities against the cancer stem cells. Preliminary studies in tumor-bearing mice supported the ability of NC to accumulate in pancreatic tumors. Conclusion: This study provides early evidence that NC-GlaB has the potential to be utilized in a preclinical setting and justifies the need to perform therapeutic experiments in mice.

Original languageEnglish
Pages (from-to)711-728
Number of pages18
JournalNanomedicine
Volume12
Issue number7
Early online date21 Mar 2017
DOIs
Publication statusPublished - 1 Apr 2017

Keywords

  • glabrescione B (GlaB)
  • Hedgehog (Hh) pathway
  • oil-cored polymeric nanocapsules

Fingerprint

Dive into the research topics of 'Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy'. Together they form a unique fingerprint.

Cite this